Abstract
Chronic graft-versus-host disease (cGVHD) is a multiorgan disorder with skin manifestations resembling scleroderma. Since photopheresis, a treatment that induces an anticlonotypic immune response, has proven to be effective in both cutaneous T cell lymphomas with circulating clonal T cells and in cGVHD, we have searched for circulating clonal T cell populations in patients with cGVHD, and determined whether T cell clonality in the blood is associated with therapeutic response. We screened blood samples from 27 patients after HLA-matched allogeneic bone marrow transplantation (allo-BMT), 10 without cGVHD and 17 with extensive cGVHD, for clonal T cell receptor γ (TCRγ) gene rearrangements using fluorescent-based polymerase chain reaction (PCR) and automated high-resolution capillary electrophoresis. Amplified populations of clonal T cells with unique TCRγ gene rearrangements were found in six of 10 (60%) allo-BMT patients without cGVHD and 13 of 17 (76.5%) allo-BMT patients with cGVHD (P = 0.41), as compared to none of 10 (0%) healthy controls. Twelve patients with cGVHD were treated by photopheresis, and the presence of amplified populations of clonal T cells was found to be associated with a cutaneous response to photopheresis, as eight of eight (100%) clone-positive vs none of four (0%) clone-negative patients experienced a clinically significant cutaneous response to treatment (P = 0.001). Our findings suggest that patients with cGVHD that have detectable expanded clonal T cell populations in their peripheral blood, may be more likely to respond to treatment by photopheresis.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Ferrara JL, Deeg HJ . Graft-versus-host disease New Engl J Med 1991 324: 667 674
Vogelsang GB . Graft-versus-host disease: implications from basic immunology for prophylaxis and treatment Cancer Treat Res 1997 77: 87 97
Atkinson K . Chronic graft-versus-host disease Bone Marrow Transplant 1990 5: 69 82
Sullivan KM, Witherspoon RP, Storb R et al. Alternating-day cyclosporine and prednisone for treatment of high-risk chronic graft-v-host disease Blood 1998 72: 555 561
Sullivan KM, Witherspoon RP, Storb R et al. Prednisone and azathioprine compared with prednisone and placebo for treatment of chronic graft-v-host disease: prognostic influence of prolonged thrombocytopenia after allogeneic marrow transplantation Blood 1998 72: 546 554
Rook AH, Suchin KR, Kao DM et al. Photopheresis: clinical applications and mechanism of action J Invest Dermatol Symp Proc 1999 4: 85 90
Rook AH, Freundlich B, Jegasothy BV et al. Treatment of systemic sclerosis with extracorporeal photochemotherapy. Results of a multicenter trial (see comments) Arch Dermatol 1992 128: 337 346
Greinix HT, Volc-Platzer B, Rabitsch W et al. Successful use of extracorporeal photochemotherapy in the treatment of severe acute and chronic graft-versus-host disease Blood 1998 92: 3098 3104
Shulman HM, Sullivan KM, Weiden PL et al. Chronic graft-versus-host syndrome in man Am J Med 1980 69: 204 217
Kneba M, Bolz I, Linke B et al. Characterization of clone-specific rearrangement T-cell receptor gamma-chain genes in lymphomas and leukemias by the polymerase chain reaction and DNA sequencing Blood 1994 84: 574 581
Luo V, Lessin SR, Wilson RB et al. Detection of clonal T-cell receptor gamma gene rearrangements using fluorescent-based PCR and automated high-resolution capillary electrophoresis Mol Diag 2001 6: 169 179
Olive C . T cell receptor usage in autoimmune disease Immunol Cell Biol 1995 73: 297 307
Vandevyver C, Mertens N, van den Elsen P et al. Clonal expansion of myelin basic protein-reactive T cells in patients with multiple sclerosis: restricted T cell receptor V gene rearrangements and CDR3 sequence Eur J Immunol 1995 25: 958 968
DerSimonian H, Sugita M, Glass DN et al. Clonal Vα12.1+ T cell expansions in the peripheral blood of rheumatoid arthritis patients J Exp Med 1993 177: 1623 1631
Celis L, Vandevyver C, Geusens P et al. Clonal expansion of mycobacterial heat-shock protein-reactive T lymphocytes in the synovial fluid and blood of rheumatoid arthritis patients Arthritis Rheum 1997 40: 510 519
Hingorani R, Choi IH, Akolkar P et al. Clonal predominance of T cell receptors within the CD8+ CD45RO+ subset in normal human subjects J Immunol 1993 151: 5762 5769
Posnett DN, Sinha R, Kabak S, Russo C . Clonal populations of T cells in normal elderly humans: the T cell equivalent to ‘benign monoclonal gammapathy’ [Published erratum appears in J Exp Med 1994; 179: 1077] J Exp Med 1994 179: 609 618
Gorochov G, Debre P, Leblond V et al. Oligoclonal expansion of CD8+ CD57+ T cells with restricted T-cell receptor beta chain variability after bone marrow transplantation Blood 1994 83: 587 595
Masuko K, Kato S, Hagihara M et al. Stable clonal expansion of T cells induced by bone marrow transplantation Blood 1996 87: 789 799
Roux E, Helg C, Dumont-Girard F et al. Analysis of T-cell repopulation after allogeneic bone marrow transplantation: significant differences between recipients of T-cell depleted and unmanipulated grafts Blood 1996 87: 3984 3992
Dumont-Girard F, Roux E, van Lier RA et al. Reconstitution of the T-cell compartment after bone marrow transplantation: restoration of the repertoire by thymic emigrants Blood 1998 92: 4464 4471
Verfuerth S, Peggs K, Vyas P et al. Longitudinal monitoring of immune reconstitution by CDR3 size spectratyping after T-cell-depleted allogeneic bone marrow transplant and the effect of donor lymphocyte infusions on T-cell repertoire Blood 2000 95: 3990 3995
Dietrich PY, Caignard A, Lim A et al. In vivo T-cell clonal amplification at time of acute graft-versus-host disease Blood 1994 84: 2815 2820
Edelson R, Berger C, Gasparro F et al. Treatment of cutaneous T-cell lymphoma by extracorporeal photochemotherapy. Preliminary results New Engl J Med 1987 316: 297 303
Heald P, Rook A, Perez M et al. Treatment of erythrodermic cutaneous T-cell lymphoma with extracorporeal photochemotherapy (see comments) J Am Acad Dermatol 1992 27: 427 433
Gottlieb SL, Wolfe JT, Fox FE et al. Treatment of cutaneous T-cell lymphoma with extracorporeal photopheresis monotherapy and in combination with recombinant interferon alfa: a 10-year experience at a single institution J Am Acad Dermatol 1996 35: 946 957
Zic JA, Stricklin GP, Greer JP et al. Long-term follow-up of patients with cutaneous T-cell lymphoma treated with extracorporeal photochemotherapy J Am Acad Dermatol 1996 35: 935 945
Duvic M, Hester JP, Lemak NA . Photopheresis therapy for cutaneous T-cell lymphoma (see comments) J Am Acad Dermatol 1996 35: 573 579
Berger CL, Perez M, Laroche L, Edelson R . Inhibition of autoimmune disease in a murine model of systemic lupus erythematosus induced by exposure to syngeneic photoinactivated lymphocytes J Invest Dermatol 1990 94: 52 57
Girardi M, Herreid P, Tigelaar RE . Specific suppression of lupus-like graft-versus-host disease using extracorporeal photochemical attenuation of effector lymphocytes J Invest Dermatol 1995 104: 177 182
Perez MI, Edelson RL, John L et al. Inhibition of antiskin allograft immunity induced by infusions with photoinactivated effector T lymphocytes (PET cells) Yale J Biol Med 1989 62: 595 609
Parkman R . Chronic graft-versus-host disease Curr Opin Hematol 1998 5: 22 25
Aractingi S, Chosidow O . Cutaneous graft-versus-host disease Arch Dermatol 1998 134: 602 612
Acknowledgements
The authors thank K Duffy, B Denardo, P Bromley and WH Macey for help in collecting clinical samples. This work was supported in part by a grant from the National Institutes of Health CA 10815, and by a grant from the Leukemia and Lymphoma Society.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
French, L., Alcindor, T., Shapiro, M. et al. Identification of amplified clonal T cell populations in the blood of patients with chronic graft-versus-host disease: positive correlation with response to photopheresis. Bone Marrow Transplant 30, 509–515 (2002). https://doi.org/10.1038/sj.bmt.1703705
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bmt.1703705
Keywords
This article is cited by
-
Extracorporeal photopheresis (photochemotherapy) in the treatment of acute and chronic graft versus host disease: immunological mechanisms and the results from clinical studies
Cancer Immunology, Immunotherapy (2014)
-
Technology Insight: ECP for the treatment of GvHD—can we offer selective immune control without generalized immunosuppression?
Nature Clinical Practice Oncology (2006)
-
Novel processes for inactivation of leukocytes to prevent transfusion-associated graft-versus-host disease
Bone Marrow Transplantation (2004)
-
Chronic graft-versus-host disease: where do we go from here?
Bone Marrow Transplantation (2004)
-
Extracorporeal Photopheresis Differentially Regulates the Expression or Phosphorylated STAT-1 and STAT-5 in Treated Monocytes and T Cells, Respectively
Journal of Cutaneous Medicine and Surgery (2004)